• Company overview
  • About Siena Biotech
  •    Mission
  •    Board of directors
  •    Management
  •    Scientific Advisory Board
  •    Ethics commitee
  •    Corporate Social Responsibility
  • Medicines Research Centre
  • Contact us
• Investors
  • MPS Foundation
• Portfolio
  • Pipeline
  • Therapeutic Areas
  •    Neurodegeneration
  •    Oncology
  • Platforms
• Partnering
  • Partnering Strategy
  • Our Partners
  • Business contacts
• News
  • News
  • Selected Publications

Who we are

Siena Biotech S.p.A. is an innovative, clinical-stage drug discovery company whose R&D efforts are focused on discovering new drugs for therapeutic intervention against neurodegenerative diseases and oncology.

Development Pipeline View Complete Pipeline  >> View Fact Sheet  >>

News 07/10/2011 Selisistat Investigator Meeting, International Meeting for the first results of Siena Biotech against Huntington  >> 03/10/2011 Siena Biotech in the European project Blueprint  >> 26/09/2011 Alessandro Padova appointed General Manager  >> 16/09/2011 Biosafety Symposium "IBP-SIVAL 2 Joint Meeting"  >> Newsletter of MPS Foundation  >>